{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:36:37Z","timestamp":1784608597463,"version":"3.55.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Tropica"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.actatropica.2017.01.005","type":"journal-article","created":{"date-parts":[[2017,1,19]],"date-time":"2017-01-19T20:04:12Z","timestamp":1484856252000},"page":"30-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Meglumine ant\u0131moniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect"],"prefix":"10.1016","volume":"169","author":[{"given":"Emrah Sefik","family":"Abamor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adil M.","family":"Allahverdiyev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melahat","family":"Bagirova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Rafailovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actatropica.2017.01.005_bib0005","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jcis.2009.03.018","article-title":"Lasting antibacterial activities of Ag-TiO2\/Ag\/a-TiO2 nanocomposite thin film photocatalysts under solar light irradiation","volume":"336","author":"Akhavan","year":"2009","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0010","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ijid.2014.04.023","article-title":"Revisiting leishmaniasis in the time of war: the Syrian conflict and the Lebanese outbreak","volume":"29","author":"Alawieh","year":"2014","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0015","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2217\/fmb.11.78","article-title":"Antimicrobial effects of TiO2 and Ag2O nanoparticles against drug-resistant bacteria and leishmania parasites","volume":"6","author":"Allahverdiyev","year":"2011","journal-title":"Future Microbiol."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0020","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.exppara.2013.06.001","article-title":"Investigation of antileishmanial activities of Tio2@Ag nanoparticles on biological properties of L. tropica and L. infantum parasites in vitro","volume":"135","author":"Allahverdiyev","year":"2013","journal-title":"Exp. Parasitol."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0025","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2337\/diacare.18.1.47","article-title":"Pentamidine-induced derangements of glucose-homeostasis \u2013 determinant roles of renal-failure and drug accumulation \u2013 a study of 128 patients","volume":"18","author":"Assan","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0030","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1645\/GE-1031R.1","article-title":"Sensitivity of Leishmania braziliensis promastigotes to MA (MA) is higher than that of other Leishmania species and correlates with response to therapy in american tegumentary leishmaniasis","volume":"93","author":"Azeredo-Coutinho","year":"2007","journal-title":"J. Parasitol."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0035","first-page":"943236","article-title":"In vitro sensitivity of paired leishmania (Viannia) braziliensis samples isolated before MA treatment and after treatment failure or reactivation of cutaneous leishmaniasis","author":"Baptista","year":"2015","journal-title":"Dis. Mark."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0040","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ijpara.2007.04.003","article-title":"Transmission of Leishmania metacyclic promastigotes by phlebotomine sand flies","volume":"37","author":"Bates","year":"2007","journal-title":"Int. J. Parasitol."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0045","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/0035-9203(86)90176-8","article-title":"Failure of MA to cure cutaneous lesions due to L major in Algeria","volume":"80","author":"Belazzoug","year":"1986","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0050","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4103\/0974-777X.62887","article-title":"Drug resistance in leishmaniasis","volume":"2","author":"Chakravarty","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0055","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1128\/AAC.01298-10","article-title":"High mortality among older patients treated with pentavalent antimonials for visceral leishmaniasis in east africa and rationale for switch to liposomal amphotericin B","volume":"55","author":"Chappuis","year":"2011","journal-title":"Antimicrob. Agents Ch."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0060","first-page":"99","article-title":"Vaccine development against leishmania donovani","volume":"15","author":"Das","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0065","first-page":"166","article-title":"A review on biology, epidemiology and public health significance of leishmaniasis","volume":"4","author":"Dawit","year":"2013","journal-title":"J. Bacteriol. Parasitol."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0070","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1258\/td.2008.080369","article-title":"Severe adverse reactions to MA in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil","volume":"39","author":"de Oliveira","year":"2009","journal-title":"Trop. Dr."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0075","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1590\/S0074-02762008000400008","article-title":"In vitro and in vivo activity of MA produced at Farmanguinhos-Fiocruz Brazil, against Leishmania (Leishmania) amazonensis, L (L.) chagasi and L (Viannia) braziliensis","volume":"103","author":"de Morais-Teixeira","year":"2008","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijpddr.2012.01.003","article-title":"Visceral leishmaniasis treatment: what do we have, what do we need and how to deliver it?","volume":"2","author":"Freitas-Junior","year":"2012","journal-title":"Int. J. Parasitol.-Drug"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0085","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1365-3083.2000.00803.x","article-title":"Garlic induces a shift in cytokine pattern in Leishmania major-infected BALB\/c mice","volume":"52","author":"Ghazanfari","year":"2000","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0090","first-page":"27","article-title":"Visceral leishmaniasis: experimental models for drug discovery","volume":"133","author":"Gupta","year":"2011","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0095","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1371\/journal.pmed.0030162","article-title":"Unresponsiveness to MA treatment in Iranian cutaneous leishmaniasis due to drug-resistant Leishmania tropica parasites","volume":"3","author":"Hadighi","year":"2006","journal-title":"PLoS Med."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0100","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/BF02977011","article-title":"Activation of murine macrophage cell line RAW 264.7 by Korean propolis","volume":"25","author":"Han","year":"2002","journal-title":"Arch. Pharm. Res."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0105","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/0140-6736(93)92327-P","article-title":"Hepatotoxicity of sodium stibogluconate in leishmaniasis","volume":"342","author":"Hepburn","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0110","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4269\/ajtmh.1992.46.296","article-title":"Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical-studies","volume":"46","author":"Herwaldt","year":"1992","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0115","first-page":"203818","article-title":"Reactive oxygen species and nitric oxide in cutaneous leishmaniasis","author":"Horta","year":"2012","journal-title":"J. Parasitol. Res."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0120","first-page":"119","article-title":"Effects of combined therapy with silymarin and MA on leishmaniasis induced by Leishmania major in BALB\/c mice","volume":"65","author":"Jabini","year":"2015","journal-title":"Drug Res."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0125","first-page":"389","article-title":"Drug unresponsiveness & combination therapy for kala-azar","volume":"123","author":"Jha","year":"2006","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0130","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"Kedzierski","year":"2006","journal-title":"Parasitology"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0135","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1016\/j.phytochem.2007.11.012","article-title":"Stimulus (polyphenol, IFN-gamma, LPS)-dependent nitric oxide production and antileishmanial effects in RAW 264.7 macrophages","volume":"69","author":"Kolodziej","year":"2008","journal-title":"Phytochemistry"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0140","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"Kumar","year":"2014","journal-title":"Clin. Transl. Immunol."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0145","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.riam.2009.06.003","article-title":"Amphotericin B: side effects and toxicity","volume":"26","author":"Laniado-Laborin","year":"2009","journal-title":"Rev. Iberoam. Micol."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0150","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00204-009-0485-0","article-title":"Genotoxic effects of the antileishmanial drug MA(A (R))","volume":"84","author":"Lima","year":"2010","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0155","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1086\/511643","article-title":"Oral pentoxifylline combined with pentavalent antimony: a randomized trial for mucosal leishmaniasis","volume":"44","author":"Machado","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0160","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1590\/S0074-02761998000200014","article-title":"Phase 1 study of an inactivated vaccine against American tegumentary leishmaniasis in normal volunteers in Brazil","volume":"93","author":"Marzochi","year":"1998","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0165","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.medmal.2004.07.032","article-title":"MA((R)) injection: benefit versus toxicity","volume":"35","author":"Masmoudi","year":"2005","journal-title":"Med. Maladies Infect."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0170","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000491","article-title":"First-Line therapy for human cutaneous leishmaniasis in Peru using the TLR7 agonist imiquimod in combination with pentavalent antimony","volume":"3","author":"Miranda-Verastegui","year":"2009","journal-title":"PLoS Neglect. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0974-777X.62883","article-title":"Treatment of visceral leishmaniasis","volume":"2","author":"Moore","year":"2010","journal-title":"J. Glob. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0180","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1590\/S0037-86821992000400006","article-title":"MA resistant Leishmania promastigotes are sensitive to pentostam","volume":"25","author":"Moreira","year":"1992","journal-title":"Rev. Soc. Bras. Med. Trop."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0185","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"Murray","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0190","doi-asserted-by":"crossref","first-page":"e1674","DOI":"10.1371\/journal.pntd.0001674","article-title":"Sodium stibogluconate (SSG) & paromomycin combination compared to SSG for visceral leishmaniasis in East Africa: a randomised controlled trial","volume":"6","author":"Musa","year":"2012","journal-title":"PLoS Negl. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0195","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1016\/j.actbio.2009.05.010","article-title":"In vitro antibacterial activity of porous TiO2-Ag composite layers against methicillin-resistant Staphylococcus aureus","volume":"5","author":"Necula","year":"2009","journal-title":"Acta Biomater."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0200","doi-asserted-by":"crossref","DOI":"10.1136\/jech.2011.142976p.69","article-title":"Systematic review of the adverse effects of cutaneous leishmaniasis treatment in the new world","volume":"65","author":"Oliveira","year":"2011","journal-title":"J. Epidemiol. Commun. Health"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0205","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1128\/CMR.18.2.293-305.2005","article-title":"Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view","volume":"18","author":"Olivier","year":"2005","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0210","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/QCO.0b013e32833fca9d","article-title":"Drug combinations for visceral leishmaniasis","volume":"23","author":"Olliaro","year":"2010","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0215","doi-asserted-by":"crossref","first-page":"5309","DOI":"10.1039\/c2tb00337f","article-title":"Biocidal properties of TiO2 powder modified with Ag nanoparticles","volume":"1","author":"Perkas","year":"2013","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0220","first-page":"502","article-title":"MA efficacy in the treatment of zoonotic cutaneous leishmaniasis","volume":"42","author":"Pourmohammadi","year":"2011","journal-title":"South East Asian J. Trop. Med."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0225","first-page":"895","article-title":"Silver nanoparticles supported on TiO2 and their antibacterial properties: effect of surface confinement and nonexistence of plasmon resonance","volume":"5","author":"Qui\u00f1ones-Jurado","year":"2014","journal-title":"Mater. Sci. Appl."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0230","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1086\/503371","article-title":"Resistance to antimony and treatment failure in human Leishmania (Viannia) infection","volume":"193","author":"Rojas","year":"2006","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003208","article-title":"Leishmaniasis in the middle east: incidence and epidemiology","volume":"8","author":"Salam","year":"2014","journal-title":"PLoS Neglect. Trop. Dis."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0240","doi-asserted-by":"crossref","first-page":"601242","DOI":"10.1155\/2012\/601242","article-title":"Leishmaniasis and climate change-case study: argentina","volume":"2012","author":"Salomon","year":"2012","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1189\/jlb.0210088","article-title":"Leishmania survival mechanisms: the role of host phosphatases","volume":"88","author":"Shio","year":"2010","journal-title":"J. Leukocyte Biol."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0250","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12034-008-0011-7","article-title":"Preparation and antibacterial activity of Ag-TiO2 composite film by liquid phase deposition (LPD) method","volume":"31","author":"Sun","year":"2008","journal-title":"Bull. Mater. Sci."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0255","first-page":"733","article-title":"Miltefosine in the treatment of leishmaniasis: clinical evidence for informed clinical risk management","volume":"3","author":"Sundar","year":"2007","journal-title":"Ther. Clin. Risk Manage."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0260","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1086\/318121","article-title":"Failure of pentavalent antimony in visceral leishmaniasis in India: report from the center of the Indian epidemic","volume":"31","author":"Sundar","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0265","doi-asserted-by":"crossref","first-page":"646932","DOI":"10.1155\/2014\/646932","article-title":"Strategies to overcome antileishmanial drugs unresponsiveness","volume":"2014","author":"Sundar","year":"2014","journal-title":"J. Trop. Med."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0270","doi-asserted-by":"crossref","first-page":"E525","DOI":"10.1016\/j.ijid.2011.03.021","article-title":"Recent advances in leishmaniasis treatment","volume":"15","author":"Tiuman","year":"2011","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0275","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1128\/AAC.01315-13","article-title":"Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis","volume":"58","author":"Trinconi","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0280","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1007\/s00125-006-0260-1","article-title":"The anti-leishmanial drug miltefosine causes insulin resistance in skeletal muscle cells in vitro","volume":"49","author":"Verma","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0285","series-title":"WHO Tech Rep Ser 793","first-page":"40","author":"WHO","year":"1990"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0290","article-title":"CONTROL OF THE LEISHMANIASES report of a meeting of the WHO expert committee on the control of leishmaniases, Geneva, 22\u201326 march 2010 introduction","author":"WHO,","year":"2010","journal-title":"Who Tech Rep Ser 949, Xii-+"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0295","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.nantod.2011.10.001","article-title":"Toxicology and clinical potential of nanoparticles","volume":"6","author":"Yildirimer","year":"2011","journal-title":"Nano Today"},{"key":"10.1016\/j.actatropica.2017.01.005_bib0300","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"van Griensven","year":"2010","journal-title":"Lancet. Infect. Dis."},{"key":"10.1016\/j.actatropica.2017.01.005_bib0305","doi-asserted-by":"crossref","DOI":"10.1088\/0957-4484\/22\/11\/115603","article-title":"Synthesis of Ag-TiO2 composite nano thin film for antimicrobial application","volume":"22","author":"Yu","year":"2011","journal-title":"Nanotechnology"}],"container-title":["Acta Tropica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X16302224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0001706X16302224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T19:17:18Z","timestamp":1568747838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0001706X16302224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":61,"alternative-id":["S0001706X16302224"],"URL":"https:\/\/doi.org\/10.1016\/j.actatropica.2017.01.005","relation":{},"ISSN":["0001-706X"],"issn-type":[{"value":"0001-706X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meglumine ant\u0131moniate-TiO2@Ag nanoparticle combinations reduce toxicity of the drug while enhancing its antileishmanial effect","name":"articletitle","label":"Article Title"},{"value":"Acta Tropica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actatropica.2017.01.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}